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strains of mice). NT cells consist of CD41CD82 andSeokmann Hong,* Alina Boesteanu,²
CD42CD82 populations (Takahama et al., 1991; AraseSebastian Joyce,² and Luc Van Kaer*
et al., 1992; Hayakawa et al., 1992; Bendelac et al., 1994)*Howard Hughes Medical Institute
and express a number of cell surface markers such asDepartment of Microbiology and Immunology
CD44 that are associated with an activation or memoryVanderbilt University School of Medicine
phenotype. Of particular interest is the observation thatNashville, Tennessee 37232
NT cells express a restricted set of TCRs that predomi-²Department of Microbiology and Immunology
nantly consists of Va14-Ja281 chains paired with one ofThe Pennsylvania State University College of Medicine
three Vb domains (Vb8.2, Vb7, or Vb2) (Koseki et al., 1991;Milton S. Hershey Medical Center
Arase et al., 1992; Lantz and Bendelac, 1994). NT cellsHershey, Pennsylvania 17033
are abundant in the thymus (Budd et al., 1987; Fowlkes
et al., 1987), constituting about 10%±20% of the adult
mature thymocyte compartment, and represent a majorSummary
population of T cells in the liver (Seki et al., 1991; Ohteki
et al., 1992; Hashimoto et al., 1995) and bone marrowMurine CD1 has been implicated in the development
(Sykes, 1990). They are also found in peripheral lym-and function of an unusual subset of T cells, termed
phoid organs such as the spleen and lymph nodes,natural T (NT) cells, that coexpress the T cell receptor
where they account for 1%±5% of the total T cell popula-(TCR) and the natural killer cell receptor NK1.1. Acti-
tion (Yankelevich et al., 1989).vated NT cells promptly produce large amounts of IL-4,
The possible involvement of NT cells in the differentia-suggesting that these cells can influence the differen-
tion of CD41 T cell subsets has been inferred from thetiation of CD41 effector T cell subsets. We have gener-
capacity of these cells to produce large amounts ofated mice that carry a mutant CD1d1 gene. NT cell
IL-4 promptly upon in vivo stimulation with anti-CD3numbers in the thymus, spleen, and liver of these mice
(Yoshimoto and Paul, 1994). Since the development ofwere dramatically reduced. Activated splenocytes
the TH2 subset of CD41 T cells is critically dependentfrom mutant mice did not produce IL-4, whereas simi-
on the presence of IL-4, it has been hypothesized thatlarly treated wild-type splenocytes secreted large
NT cells may promote the generation of TH2 responses.amounts of this cytokine. These results demonstrate
Studies with mouse strains such as SJL that have re-a critical role for CD1 in the positive selection and
duced numbers of NT cells support this idea. In these
function of NT cells.
mice, injection of anti-CD3 does not induce a burst of
IL-4, and polyclonal stimulation of B cells with anti-IgD
Introduction antibodies does not induce the production of IgE anti-
bodies (Yoshimoto et al., 1995a). However, the exact
The development of CD41 effector T cell subsets is role of NT cells in the development of a TH2 response
critically dependent on changes in the cytokine milieu remains to be determined.
early in an infection. Studies with neutralizing antibodies The ligand specificity of NT cells remains poorly un-
(Belosevic et al., 1989; Le Gros et al., 1990; Swain et al., derstood. It appears that NT cells can develop in the
1990; Seder et al., 1992; Sypec et al., 1993; Heinzel et thymus but also in several extrathymic tissues such as
al., 1995) and with mice carrying disruptions in cytokine the liver (Levitsky et al., 1991; Kikly and Dennert, 1992;
genes (Kuhn et al., 1991; Wang et al., 1994; Magram et Makino et al., 1993; Bendelac et al., 1994; Sato et al.,
al., 1996) have demonstrated that the development of 1995; Makino et al., 1996). Unlike the mainstream ab T
the inflammatory (TH1) T cell subset depends on the cells that require specialized epithelial cells for their
cytokines interleukin-12 (IL-12) and IFNg, while the de- development, NT cells require the expression of an en-
velopment of the helper (TH2) T cell subset depends dogenous ligand on hematopoietic cells (Bix et al., 1993;
on IL-4. The cell source that produces IL-4 early in an Bendelac et al., 1994; Ohteki and MacDonald, 1994).
immune response remains unclear (Swain, 1995). Al- Since the expression of this ligand is dependent on the
though mast cells, basophils, and eosinophils have been expression of b2-microglobulin (b2m) (Bendelac et al.,
implicated in the early production of IL-4 (Seder et al., 1994; Coles and Raulet, 1994; Ohteki and MacDonald,
1991; Bradding et al., 1992; Moqbel et al., 1995), they 1994), but not the transporter associated with antigen
do not seem to be required for the production of immu- processing (TAP) (Adachi et al., 1995; Joyce et al., 1996),
noglobulin E (IgE) antibodies in vivo (Schmitz et al., 1994). it seems likely that NT cells recognize a b2m-associated
A recently characterized subset of T cells, termed molecule that does not require peptide transport by TAP
natural T (NT) cells, has been implicated in the produc- for its assembly and surface expression. In the mouse,
tion of IL-4 early in an immune response. NT cells are there are two such molecules: CD1 (Brutkiewicz et al.,
unusual in that they share receptor structures common 1995; Joyce et al., 1996) and the thymus leukemia (TL)
to both mainstream T cells and natural killer (NK) cells antigen (Holcombe et al., 1995; Joyce et al., 1996). CD1
(Bendelac, 1995a; Bix and Locksley, 1995; MacDonald, (Porcelli, 1995) and TL (Old et al., 1963; Flaherty et al.,
1995; Vicari and Zlotnik, 1996). In the mouse, NT cells 1990) belong to a large group of nonclassic class Ib
molecules that are structurally related to the classicalcoexpress intermediate levels of the ab T cell receptor
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antigen-presenting major histocompatibility complex Results
(MHC) class I molecules H2-K, H2-D, and H2-L (Stroy-
nowski, 1990; Shawar et al., 1994). CD1 is expressed in Generation of CD1d1 Mutant Mice
many different tissues but is particularly abundant on Mouse CD1 is encoded by two genes, CD1d1 and
the surface of cortical thymocytes (Bradbury et al., 1990; CD1d2, that share a high degree of nucleotide sequence
Bendelac, 1995b). TL is expressed in epithelial cells of identity (Bradbury et al., 1988). The product of the CD1d1
the small intestine of most strains of mouse and in the gene is recognized by all anti-CD1 antibodies that have
thymus of only those strains that carry the H2-T18 gene been described, whereas surface expression of the
(Bradbury et al., 1988; Hershberg et al., 1990; Wu et CD1d2 product has not yet been demonstrated (Porcelli,
al., 1991). Several lines of evidence suggest that these 1995). In addition, the predicted a2 domain of the CD1d2
nonclassic class Ib molecules can function as ligands gene product lacks an intradomain disulfide bond that
for NT cells. This was convincingly shown for CD1 by is found in the a2 domain of all published classic and
the analysis of autoreactive T cell hybridomas that coex- nonclassic MHC class I molecules (Bradbury et al., 1988;
press the invariant NT cell receptor and NKR-P1. These Stroynowski, 1990; Porcelli, 1995). This disulfide bond
hybridomas were able to react with CD1-expressing thy- is thought to be critical for the folding of the antigen-
mocytes and with fibroblasts that were infected with a binding groove (Bjorkman et al., 1987). Thus, the CD1d2
vaccinia construct containing the mouse CD1d1 cDNA gene may not encode a functional antigen-presenting
(Bendelac et al., 1995). Evidence that TL plays a role in molecule, and all functions previously attributed to
the ligand recognition of NT cells is indirect and comes mouse CD1 may be effected by the product of the
from studies with TAP-deficient and TL-congenic or TL- CD1d1 gene. For this reason, we decided to introduce
transgenic mice (Joyce et al., 1996). Although both a targeted mutation into the CD1d1 gene, while leaving
mouse CD1 (CastaÄ o et al., 1995) and TL (Sharma et al., CD1d2 intact.
1996) are known to bind peptides, it is unclear whether The CD1d1 mutation was created by the replacement
a peptide is involved in the recognition of these mole- of a 200 bp fragment from the third exon of CD1d1,
cules by NT cells. which encodes the a2 domain, with a neomycin (neo)
To evaluate the role of CD1 in the development and resistance gene in strain 129/Sv-derived embryonic
function of NT cells, we have generated a mouse strain stem (ES) cells (Figure 1). Mutant ES cell clones were
that lacks the CD1d1 gene. To avoid contributions of injected into mouse blastocysts to generate chimeric
TL to the NT cell repertoire, we performed our analysis mice, which were subsequently scored for transmission
in mice that do not express TL in the thymus. Our results of the mutant CD1d1 allele through the germline by mat-
show that CD1d1 deficiency leads to a strong reduction ing with C57BL/6 mice. Heterozygous mutant animals
of NT cell numbers in the thymus, spleen, and liver, were intercrossed toobtain (C57BL/6x129/Sv) F2 homo-
accompanied by a dramatic decrease in early IL-4 pro- zygous mutants. Mutant mice were raised under specific
duction by splenic T cells treated in vivo with anti-CD3. pathogen-free conditions; they appeared to be healthy
These data demonstrate an important role for CD1 in and bred normally.
In addition to CD1, the TL antigen may be involved inthe development and ligand specificity of NT cells.
Figure 1. Generation of CD1d1 Mutant Mice
(A) The CD1d1 locus and targeting construct.
The CD1d1 locus is shown along with the
position of the CD1d2 gene. A 200 bp frag-
ment from the third exon of CD1d1 gene was
replaced with a neomycin resistance (neo)
gene. Hybridization probes (a 59 external
probe and a 39 internal probe) used for
screening of ES cell clones and mice are indi-
cated, together with the expected sizes of
hybridizing restriction fragments in wild-type
and mutant CD1d1 alleles. Restriction sites:
RI, EcoRI; KI, KpnI.
(B) Southern blot analysis of representative
ES clones and tail biopsies. Genomic DNA
was isolated from an ES cell clone with a
mutant CD1d1 allele and from a wild-type
control, digested with EcoRI, and hybridized
with the 59 probe (see [A]). Tail DNA was pre-
pared from wild-type, heterozygous mutant,
and homozygous mutant mice; digested with
EcoRI or KpnI; and hybridized with the 59 or 39




the development and specificity of NT cells (Joyce et
al., 1996). Because the ES cells and mouse strain used
to generate mutant animals differ in their TL status (129/
Sv is a TL1 strain and C57BL/6 is a TL2 strain), all mice
used in this study were genotyped for TL. To exclude
phenotypic effects caused by the expression of TL, only
TL2 mice were used in the experiments described be-
low. Absence of TL expression in the thymus of these
mice was confirmed by staining with an anti-TL antibody
(data not shown).
Thymocytes from Mutant Mice Lack
CD1 Expression
To determine the effect of the CD1d1 mutation on cell
surface CD1 expression, we stained thymocytes from
mutant and wild-type mice with the anti-CD1 mono-
clonal antibody 3C11. Thymocytes from CD1d1 mutant
mice did not show any detectable staining with this
antibody (Figure 2A). To confirm this finding, we stimu-
lated a CD1-specific NT cell hybridoma, DN32.D3 (Ben-
delac et al., 1995), with thymocytes isolated from mutant
and wild-type animals. While thymocytes from wild-type
mice were efficiently recognized by the hybridoma, simi-
lar cells from mutant mice were not recognized (Figure
2B). Thus, CD1d1 mutant mice lack CD1 expression.
However, mutant and wild-type thymocytes expressed
similar levels of the classic MHC class I molecule H2-
Kb (Figure 2A).
The Ontogeny of NT Cells Is Affected
Figure 2. Thymocytes from CD1d1 Mutant Mice Lack Cell Surfacein CD1d1 Mutant Mice
CD1 ExpressionReduced Numbers of NT Cells in the Thymus
(A) Flow cytometric analysis of CD1 surface expression. ThymocytesIn wild-type mice, NT cells constitute 10%±20% of the ma-
from wild-type and mutant mice were stained with the anti-CD1
ture thymocyte population (Budd et al., 1987; Fowlkes monoclonal antibody 3C11 and analyzed by flow cytometry. As a
et al., 1987). Since CD1 has been implicated in the devel- control, thymocytes were also stained with the MHC class I H2-
Kb±specific antibody Y-3.Results for stained and unstainedsamplesopment of NT cells in the thymus (Bendelac et al., 1994;
are indicated.Coles and Raulet, 1994; Bendelac, 1995b), we deter-
(B) Recognition by an NT cell hybridoma. Cells (5 3 105) of the CD1-mined the prevalence of thymic NT cells in CD1d1 mu-
specific DN32.D3 NT cell hybridoma were incubated alone (2) or
tant mice. Thymocytes from mutant and wild-type animals with 5 3 105 thymocytes from mutant or wild-type mice for 24 hr,
depleted of CD81 and immature heat-stable antigen after which IL-2 levels in the supernatant were measured using HT-2
(HSA)±positive cells were stained with anti-CD44 and indicator cells. Results are expressedas the amount of [3H]thymidine
incorporated into the DNA of HT-2 cells.anti-NK1.1 monoclonal antibodies. This population of T
cells is reduced 5- to 6-fold in the thymus of mutant
animals (Figure 3), indicating that the absence of CD1d1
has a dramatic effect on NT cell development. Since 1994; Makino et al., 1995). We thus compared the preva-
lence of NT cells in the spleens of mutant and wild-NT cells in the thymus include both CD41CD82 and
CD42CD82 populations, we also stained HSA2 CD82 type animals. Percentages of NT cells, as measured by
staining with anti-TCR and anti-NK1.1 antibodies, werethymocytes with anti-CD4 and anti-NK1.1 antibodies.
Percentages of CD41 NK1.11 cells were more dramati- reduced 3- to 5-fold (Figure 3). Staining with anti-CD4
and anti-NK1.1 antibodies also revealed that thecally reduced (10- to 20-fold) than were percentages
of CD42CD82 NK1.11 cells (4- to 5-fold). The relative CD41CD82 NT cell population was reduced about 10-
fold, while the CD42CD82 NT cell population showed anumbers of CD42CD82 double-negative thymocytes, of
CD41CD82 and CD42CD81 single-positive thymocytes, reduction of about 2-fold. The relative numbers of CD41
and CD81 T cells and of NK cells were unaltered in theand of CD41CD81 double-positive thymocytes ap-
peared normal in mutant animals (data not shown). spleen and blood of mutant animals (Figure 3 and data
not shown).Reduced Numbers of NT Cells in Peripheral
Lymphoid Organs Reduced Numbers of NT Cells in the Liver
We also compared numbers of NT cells in the liver,CD1 has also been implicated in the selection of NT
cells in peripheral lymphoid organs such as the spleen, where these cells are normally prevalent (Seki et al.,
1991; Ohteki et al., 1992; Hashimoto et al., 1995). Thewhere they constitute about 1%±5% of the total popula-
tion of T cells (Makino et al., 1993; Yoshimoto and Paul, percentages of CD41CD82 NT cells in mutant mice
Immunity
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Figure 3. CD1d1 Mutant Mice Have Dramati-
cally Reduced Numbers of NT Cells
Numbers of NT cells were determined in the
thymus, spleen, and liver, as indicated. For
staining of thymic NT cells, thymocytes were
first depleted of HSA1 and CD81 cellsand sub-
sequently stained with anti-CD44 and anti-
NK1.1, or were stained with anti-CD4 and
anti-NK1.1 antibodies.For staining of NTcells
in the spleen and liver, cell suspensions were
first depleted of B cells and macrophages
and subsequently were stained with anti-CD4
and anti-NK1.1 antibodies or anti-TCR and
anti-NK1.1 antibodies. Relevant populations
of lymphocytes are boxed; numbers above
the boxed regions represent percentages of
lymphocytes in that region among total num-
bers of cells.
were reduced about 8-fold, whereas percentages of than those produced by wild-type animals (a 9- to 25-
fold difference). The levels of IL-4 secreted by mutantCD42CD82 NT cells were reduced 2-fold (Figure 3).
Taken together, our flow cytometric data demonstrate splenocytes are comparable to the levels of IL-4 pro-
duced by spleen cells from untreated mice (Figure 4A).that CD1d1 is a ligand for the positive selection of NT
cells. Anti-CD3 injection also had a profound effect on the
production of IFNg by splenic T cells from mutant mice
(Figure 4B). Although the mutant animals produced sig-Mutant Mice Do Not Secrete IL-4 In Vivo
nificantly higher levels of IFNg compared to untreatedin Response to TCR Cross-Linking
animals, the amounts of IFNg produced were 2±9 timesNT cells, upon activation of their TCR by cross-linking
lower than those produced by wild-type animals. Thus,with anti-CD3, produce a burst of IL-4 within 90 min of
CD1d1-restricted NT cells are a potent source of IL-4treatment (Yoshimoto and Paul, 1994). NT cells may
in vivo.therefore make a significant contribution to the differen-
tiation of CD41 T cell subsets, polarizing the immune
response toward the production of TH2 cells. Therefore, IgE Production in Mutant Mice
Is Relatively Unalteredif indeed CD1d1-restricted NT cells are a major source
of early IL-4, the mutant mice would be expected to be Mice that genetically lack NT cells, such as SJL and
b2m mutant mice, are deficient in the production of IgEdefective in its production. CD1d1 mutant mice were
injected intravenously with anti-CD3 and IL-4 production antibodies upon polyclonal stimulation of B cells with
anti-IgD antisera (Yoshimoto et al., 1995a, 1995b). Weby splenocytes was measured. Mutant mice treatedwith
anti-CD3 produce IL-4 levels that are dramatically lower therefore tested the production of IgE antibodies by
CD1d1 Mutant Mice
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Figure 4. IL-4 and IFNg Production Is Dramatically Altered in CD1d1
Mutant Mice Figure 5. The IgE Response Is Unaltered in CD1d1 Mutant Mice
Wild-type and mutant mice were injected intravenously with 1 mg Wild-type and mutant mice were injected subcutaneously with 100
anti-CD3. Ninety minutes later, spleens were harvested and cell ml of goat anti-mouse IgD serum. Blood from mice was collected 8
suspensions were incubated in 2 ml of medium at 378C for 2 hr. days after injection and tested for levels of IgE antibodies by ELISA.
Culture supernatants were tested for (A) IL-4 and (B) IFNg titers by Three representative experiments with one wild-type and one mu-
ELISA. Data are shown for an experiment with three wild-type and tant mouse each are shown.
three mutant mice. As a control, IL-4 and IFNg levels were also
measured in similarly treated splenic cell suspensions from a
C57BL/6 mouse that was not injected with anti-CD3. disulfide bond within its a2 domain (Bradbury et al.,
1988), suggest that the product of the CD1d2 gene may
not be a restriction element for T cell responses.
CD1d1 mutant mice 1 week after subcutaneous injection The cytokine IL-4 is thought to be critically important
of goat anti-mouse IgD serum. The IgE response in- for the development of the TH2 helper T cell subset and
duced by this treatment in mutant and wild-type mice for the production of IgE antibodies (Le Gros et al., 1990;
is not significantly different (Figure 5). Thus, CD1d1- Swain et al., 1990; Kuhn et al., 1991; Seder et al., 1992).
restricted NT cells do not appear to be absolutely re- It was therefore surprising that IgE responses were not
quired for the development of an IgE response. significantly altered upon polyclonal activation of B cells
from mutant mice with anti-IgD antibodies (Figure 5).
One possible explanation for this result is the geneticDiscussion
background of the mice used in this study: we studied
mutant mice and their wild-type littermates on a mixedIn this report we describe the initial characterization
of mice with a defective CD1d1 gene, which has been (C57BL/6x129/Sv) background. Because the production
of IgE by treatment with anti-IgD varies widely amongimplicated in the development and ligand specificity of
NT cells (Bix et al., 1993; Bendelac et al., 1994; Ohteki different mouse strains (Yoshimoto et al., 1995a), it is
possible that our result was caused by this mixed back-and MacDonald, 1994; Bendelac, 1995b; Bendelac et
al., 1995). Our results provide strong support for this ground. IL-4 could be produced by cell types other than
NT cells in different mouse strains. With regard to thehypothesis. First, NT cells in the thymus, spleen, and
liver are reduced 5- to10-fold (Figure 3). Second, spleno- genetic background of mice, it is also worthwhile to
note that the experiments suggesting that NT cells arecytes from mutant mice produce very little IL-4 upon in
vivo activation with anti-CD3. The levels of IL-4 pro- important for the production of IgE upon polyclonal acti-
vation of B cells were performed with b2m-deficient miceduced by mutant mice are indistinguishable from those
produced by untreated mice. Together, these findings that had been backcrossed multiple times with strain
C57BL/6 mice (Yoshimoto et al., 1995b). Another possi-clearly demonstrate a critical role for CD1d1 in thedevel-
opment of NT cells. Furthermore, these data provide bility is that stimuli other than IL-4 may contribute to
the production of IgE. Recent studies with IL-4±deficientconclusive evidence that the large amounts of IL-4 pro-
duced upon treatment of wild-type mice with anti-CD3 mice suggest that this may be the case: B cells from
these mice, upon polyclonal activation with anti-IgD, areis produced by NT cells.
Mouse CD1 is encoded by two genes, CD1d1 and able to secrete IgE antibodies (Morawetz et al., 1996).
Recent studies with b2m-deficient mice that lack NTCD1d2 (Bradbury et al., 1988; Porcelli, 1995). Our data
suggest that the product of the CD1d2 gene from the cells have challenged the role attributed to these cells
in the differentiation of TH2 cells (Brown et al., 1996;129/Sv strain (from which ES cells were used for the
introduction of a targeted mutation in the CD1d1 gene) Zhang et al., 1996). In b2m mutant mice, immunization
with a number of different protein antigens or parasitesis not important for the development and function of NT
cells. Although it is possible that the product of the or induction of airway hyperactivity to aerosolized anti-
gens led to normal TH2 type immune responses and theCD1d2 gene has functions that have not yet been de-
fined, the present data, together with the observation generation of IgE antibodies. Although these findings
suggest that NT cells are not an important source for
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individual clones was digested with EcoRI and hybridized with a 2.3the production of IL-4 in these immune responses, an
kb ClaI±EcoRI probe from the 59 end of the CD1d1 gene (Figure 1A).alternative explanation is possible. b2m-deficient mice
Recombination was confirmed by digestion with KpnI and hybridiza-not only lack CD1 surface expression and NT cells; they
tion with a 700 bp BamHI±EcoRI probe from the 39 end of the CD1d1
also are deficient in the surface expression of most clas- gene (Figure 1A). Chimeric mice were generated as described pre-
sic and nonclassic MHC class I molecules, have strong viously (Van Kaer et al., 1992). Chimeric mice were mated with
C57BL/6 mice to score for germline transmission, and heterozygousreductions in their numbers of CD81 T lymphocytes
mutant mice were intercrossed to obtain (C57BL/6x129/Sv) F2 ho-(Koller et al., 1990; Zijlstra et al., 1990), and exhibit alter-
mozygous mutants. All mice used in this study were either F2 or F3ations in the reactivities of their NK cells (Bix et al., 1991;
animals. Mice were typed for their CD1d1 status by genomic South-Liao et al., 1991). These additional defects may influence
ern blotting with the 59 probe. Mice were housed under specific
immune responses. It is therefore difficult to draw any pathogen-free conditions.
definite conclusion from these immunization studies. It To type mice for their TL status, tail DNA was digested with BglII
andhybridized with a TL-specific probe that detects a polymorphismshould be possible to determine the precise role of NT
between strains 129/Sv (TL1) and C57BL/6 (TL2) (Pontarotti et al.,cells in the differentiation of T cell subsets by infection
1986). This probe was generated by polymerase chain reactionusingand immunization studieswith theCD1d1-deficient mice
a set of primers designed on the basis of published sequencesreported here.
(Pontarotti et al., 1986): 59-TATACAGAGCTCCGTAGGAC-39 and
Although NT cells have been implicated in the early 59-AGTTGTCTGCAGCCACGAAC-39. All mice used inthis study were
production of IL-4 in an immune response, our studies TL2.
show that these cells also provide a significant source
for the production of IFNg, a cytokine implicated in the
Antibodies and Antisera
differentiation of TH1 cells (Belosevic et al., 1989; Wang The phycoerythrin-labeled anti-NK1.1 antibody PK136 (mouse
et al., 1994). Although both wild-type and mutant mice IgG2a), anti-HSA (CD24) antibody J11d (rat IgM), fluorescein isothio-
cyanate±labeled anti-CD4 antibody RM4±5 (rat IgG2a), fluoresceinproduced high amounts of IFNg upon stimulation with
isothiocyanate±labeled anti-CD44 antibody IM7 (rat IgG2b), anti-anti-CD3, levels in mutant mice were reduced 3- to
CD45R (B220) (rat IgG2a), and anti-CD3 antibody 145±2C11 (Arme-4-fold compared to those from wild-type mice (Figure
nian hamster IgG) used for intravenous injections were obtained4B). Production of IFNg by NT cells has been reported
from Pharmingen. The anti-H2-Kb antibodyY-3 (IgG2b) was obtained
before (Yoshimoto et al., 1995b), but its relevance to the from Dr. Stanley Nathenson (Albert Einstein College of Medicine,
differentiation of CD41 T cells is unclear. In this regard, New York, NY). The anti-CD1 antibody 3C11 (rat IgM) (Bleicher et
al., 1990) was obtained from Dr. Steven Balk (Beth Israel Hospital,it is noteworthy that NT cells have been implicated in the
Boston, MA). The anti-TL antibody HD168 (Obata et al., 1985) wasdifferentiation of TH1 cells during the immune response
obtained from Mitchell Kronenberg (University of California, Losagainst the lethal parasite Toxoplasma gondii (Denkers
Angeles, CA). Anti-CD8 antibody 2.43 (Sarmiento et al., 1980) usedet al., 1996). Thus, NT cells may contribute not only
for panning was obtained from Dr. Barney Graham (Vanderbilt Uni-
to the generation of a TH2 response but also to the versity). The rabbit anti-rat IgG (whole molecule) antiserum was
development of a TH1 response. An interesting possibil- obtained from Cappel. The goat anti-mouse IgD antiserum (Finkel-
man et al., 1987) used for injection of mice was generously providedity would be that IL-4 and IFNg are produced by distinct
by Dr. Fred Finkelman (University of Cincinnati, OH). Rat anti-mousesubsets of NT cells. If so, NT cells could contribute to
IL-4 11B11 (IgG1), biotinylated rat anti-mouse IL-4 BVD6±24G2the development of an adaptive immune response in
(IgG1), rat anti-mouse IFNg R4±6A2 (IgG1), biotinylated rat anti-ways that are more intricate than previously thought.
mouse IFNg XMG1.2 (IgG1), rat anti-mouse IgE R35±72 (IgG1), and
In addition to their role in the differentiation of effector biotinylated rat anti-mouse IgE R35±118 (IgG1) used for enzyme-
T cell subsets, mouse NT cells have been implicated in linked immunosorbent assays (ELISA) were obtained from Phar-
mingen.the control of autoimmune responses (Mieza et al.,
1996), in the inhibition of experimental tumor metastasis
(Takeda et al., 1996), and in mechanisms of immunologi- Flow Cytometric Analyses
cal tolerance (Crispe and Mehal, 1996). The precise role Cell suspensions from thymus and spleen were prepared according
to standard procedures. Lymphocytes from liver were obtained asof NT cells in each of these and in other immune re-
described previously (Sato et al., 1995). Briefly, the liver was pressedsponses can now be directly tested with the CD1d1
through a 200-gauge stainless steel mesh and suspended in RPMImutant mice described here.
medium. After two washes with RPMI, mononuclear cells were iso-
lated by Ficoll-Isopaque density (r 5 1.090) gradient centrifugation.
Mononuclear cells were collected from the interface and washedExperimental Procedures
twice with RPMI±10% fetal calf serum (FCS) before use in staining
experiments.Generation of CD1d1 Mutant Mice
The CD1d1 gene was isolated from a strain 129/Sv phage library For staining of NT cells, mice were first typed for the expression
of NK1.1 by staining of blood NK cells with the PK136 antibody.with a probe generated by polymerase chain reaction. The targeting
construct was prepared using a 2.8 kb ApaI fragment containing Thymocytes or spleen cell suspensions from NK1.11 mice were then
incubated on ice for 1 hr with anti-CD8 culture supernatant and anti-the 59 region of the CD1d1 gene, a 3.2 kb BamHI±NotI fragment
containing the 39 region of the CD1d1 gene (the NotI site in this HSA or -B220, respectively. After washing three times, the stained
cell suspensions were plated on rabbit anti-rat IgG coated platesfragment comes from the pBluescript vector into which phage DNA
was initially subcloned), a neomycin resistance gene (neo) (obtained (washed and blocked with 5% FCS) and incubated at 48C for 1 hr.
Panning plates were prepared by adsorbing 8 ml of a 10 mg/mlfrom Dr. Michael Rudnicki, McMaster University, Hamilton, Ontario,
Canada), and the pBluescript plasmid (Stratagene). This construct solution of rabbit anti-rat IgG serum in 0.05 M Tris buffer (pH 9.5)
onto Petri dishes overnight at 48C. Nonadherent cells were collectedwas designed to delete a fragment of about 200 bp from the exon
encoding the a2 domain of CD1d1. The strain 129/Sv±derived ES and used for staining and fluorescence-activated cell sorter
analysis.cell line TL1 (obtained from Dr. Trish Labosky and Dr. Brigid Hogan,
Vanderbilt University) was transfected with the NotI-linearized tar- Antibody stainings were performed by incubating cells with the
antibody on ice for 1 hr followed by several washes. Cells weregeting vector. G418-resistant colonies were selected and isolated
as previously described (Van Kaer et al., 1992). Genomic DNA from analyzed using a FACScan flow cytometer (Becton Dickinson). Dead
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cells were excluded from the analysis based on their forward and References
sideways light-scattering properties.
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